2016. Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial. Swiss Medical Weekly. 146, 0102 (Jan. 2016), w14274. DOI:https://doi.org/10.4414/smw.2016.14274.